- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: rituximab [MabThera/Rituxan]
Total 3381 results
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); Janssen, LPCompletedCD20 Positive | Ann Arbor Stage II Follicular Lymphoma | Ann Arbor Stage III Follicular Lymphoma | Ann Arbor Stage IV Follicular Lymphoma | Grade 1 Follicular Lymphoma | Grade 2 Follicular Lymphoma | Grade 3a Follicular Lymphoma | Ann Arbor Stage II Marginal Zone Lymphoma | Ann Arbor Stage III Marginal... and other conditionsUnited States
-
University Hospital, ToursCompleted
-
Shandong UniversityCompletedPurpura, Thrombocytopenic, Idiopathic | Immune ThrombocytopeniaChina
-
Cliniques universitaires Saint-Luc- Université...Terminated
-
The Korean Society of Hematopoietic Stem Cell TransplantationHoffmann-La RocheUnknownSteroid-Refractory Chronic GVHDKorea, Republic of
-
Genentech, Inc.AbbVie (prior sponsor, Abbott)CompletedChronic Lymphocytic LeukemiaUnited States, France, Germany
-
Loxo Oncology, Inc.Eli Lilly and CompanyActive, not recruitingB-cell Lymphoma | Waldenstrom Macroglobulinemia | Mantle Cell Lymphoma | Marginal Zone Lymphoma | Chronic Lymphocytic Leukemia | Small Lymphocytic LymphomaUnited States, Korea, Republic of, Australia, Japan, United Kingdom, Italy, Poland, France, Switzerland, Sweden
-
Karolinska InstitutetActive, not recruitingMultiple Sclerosis, Relapsing-RemittingSweden
-
Hoffmann-La RocheCompletedLymphocytic Leukemia, ChronicGermany
-
Hoffmann-La RocheCompletedLymphocytic Leukemia, ChronicGreece
-
Hoffmann-La RocheCompletedOff-Label UseSpain, France, Italy, United Kingdom, Germany
-
University Hospital, ToursRoche Pharma AG; French Innovative Leukemia OrganisationCompleted
-
Anders SvenningssonVästerbotten County Council, SwedenCompletedProgressive Multiple SclerosisSweden
-
Hoffmann-La RocheCompletedRheumatoid ArthritisSerbia
-
Hoffmann-La RocheCompleted
-
Fundación Pública Andaluza Progreso y SaludMinistry of Health, SpainTerminated
-
National Cancer Institute (NCI)Celgene CorporationActive, not recruitingAnn Arbor Stage III Grade 1 Follicular Lymphoma | Ann Arbor Stage III Grade 2 Follicular Lymphoma | Ann Arbor Stage IV Grade 1 Follicular Lymphoma | Ann Arbor Stage IV Grade 2 Follicular Lymphoma | Ann Arbor Stage II Grade 3 Contiguous Follicular Lymphoma | Ann Arbor Stage II Grade 3 Non-Contiguous... and other conditionsUnited States
-
National Cancer Institute (NCI)CompletedRefractory B-Cell Non-Hodgkin Lymphoma | Recurrent B-Cell Non-Hodgkin Lymphoma | CD20 PositiveUnited States
-
Centre Hospitalier de PAUUniversity Hospital, BordeauxCompletedNervous System Diseases | Multiple Sclerosis, Chronic ProgressiveFrance
-
AbbVieGenentech, Inc.Active, not recruitingNon-Hodgkin's Lymphoma | Hematological Malignancies | Chronic Lymphoid Leukemia | CD20-Positive Lymphoid MalignanciesUnited States, Australia
-
Hoffmann-La RocheTerminated
-
Mayo ClinicNational Cancer Institute (NCI)WithdrawnExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Adult Diffuse Mixed Cell Lymphoma | Recurrent Adult Diffuse Small Cleaved Cell Lymphoma and other conditions
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI); American Cancer Society, Inc.CompletedExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Adult Diffuse Mixed Cell Lymphoma | Recurrent Adult Diffuse Small Cleaved Cell Lymphoma and other conditionsUnited States
-
National Cancer Institute (NCI)CompletedExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Diffuse Small Cleaved Cell Lymphoma | Recurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Mantle Cell Lymphoma | Recurrent... and other conditionsUnited States
-
National Cancer Institute (NCI)WithdrawnExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Mantle Cell Lymphoma | Recurrent Marginal Zone Lymphoma | Splenic Marginal Zone LymphomaUnited States
-
University of WashingtonMerck Sharp & Dohme LLCActive, not recruitingRecurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Recurrent Follicular Lymphoma | Refractory Follicular LymphomaUnited States
-
Hoffmann-La RocheCompletedLymphoma, Non-Hodgkin | Leukemia, Lymphocytic, Chronic, B-CellKorea, Republic of
-
Hoffmann-La RocheCompletedFollicular LymphomaSerbia
-
Singapore General HospitalJanssen-Cilag Ltd.CompletedDiffuse Large B-Cell LymphomaSingapore
-
University of WashingtonMillennium Pharmaceuticals, Inc.Active, not recruitingFollicular Lymphoma | Waldenstrom Macroglobulinemia | Mantle Cell Lymphoma | Marginal Zone Lymphoma | Chronic Lymphocytic Leukemia | Lymphoplasmacytic Lymphoma | Small Lymphocytic Lymphoma | Recurrent Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue | Refractory Extranodal Marginal...United States
-
National Cancer Institute (NCI)Not yet recruitingClassic Follicular Lymphoma | Follicular Lymphoma With Unusual Cytological Features
-
Hannover Medical SchoolGerman Federal Ministry of Education and ResearchTerminatedAcute RejectionGermany
-
Hoffmann-La RocheCompletedLymphoma, FollicularSerbia
-
Hoffmann-La RocheCompleted
-
Royal Liverpool University HospitalHoffmann-La Roche; University of LiverpoolCompleted
-
Hoffmann-La RocheCompletedFollicular LymphomaGermany
-
University Hospital, RouenCompletedBullous PemphigoidFrance
-
Technical University of MunichUniversity Hospital, Essen; University of Erlangen-Nürnberg; Heinrich-Heine University... and other collaboratorsTerminatedRenal Transplantation | Transplantation, Kidney | Chronic Allograft Nephropathy | GraftingGermany
-
Massachusetts General HospitalGenentech, Inc.WithdrawnKidney Insufficiency | Chronic Rejection
-
Massachusetts General HospitalGenentech, Inc.; BiogenWithdrawn
-
Genentech, Inc.CompletedMicroscopic Polyangiitis | Granulomatosis With PolyangiitisUnited States
-
Johns Hopkins UniversityCompletedPrimary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States
-
Massachusetts General HospitalGenentech, Inc.CompletedSialadenitis | Retroperitoneal Fibrosis | Autoimmune Pancreatitis | Pseudotumor
-
University of Kansas Medical CenterCompletedNon-Hodgkins LymphomaUnited States
-
University of California, San FranciscoGenentech, Inc.CompletedInflammation | Rheumatoid Arthritis | Endothelial FunctionUnited States
-
Mayo ClinicGenentech, Inc.; Biogen; National Center for Research Resources (NCRR)TerminatedPrecancerous ConditionUnited States
-
Gaylis, Norman B., M.D.Genentech, Inc.; Oklahoma Medical Research FoundationCompletedRheumatoid ArthritisUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingGrade 3a Follicular Lymphoma | Ann Arbor Stage III Grade 1 Follicular Lymphoma | Ann Arbor Stage III Grade 2 Follicular Lymphoma | Ann Arbor Stage IV Grade 1 Follicular Lymphoma | Ann Arbor Stage IV Grade 2 Follicular Lymphoma | Ann Arbor Stage III Grade 3 Follicular Lymphoma | Ann Arbor Stage...United States
-
Emory UniversityNational Cancer Institute (NCI); National Institutes of Health (NIH); Millennium...Active, not recruitingMantle Cell LymphomaUnited States